Genomic Valley

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE574D01010
  • NSEID:
  • BSEID: 539206
INR
26.67
1.27 (5.0%)
BSENSE

May 21

BSE+NSE Vol: 3.54 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 493236,
    "name": "Genomic Valley",
    "stock_name": "Genomic Valley",
    "full_name": "Genomic Valley Biotech Ltd",
    "name_url": "stocks-analysis/genomic-valley",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.67",
    "chg": 1.27,
    "chgp": "5.0%",
    "dir": 1,
    "prev_price": "25.40",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539206,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE574D01010",
    "curr_date": "May 21",
    "curr_time": "",
    "bse_nse_vol": "3.54 k",
    "exc_status": "Active",
    "traded_date": "May 21, 2026",
    "traded_date_str": "2026 05 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genomic-valley-493236-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Genomic Valley Biotech Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-genomic-valley-biotech-ltd-3999772",
        "imagepath": "",
        "date": "2026-05-19 23:18:37",
        "description": "The next results date for Genomic Valley Biotech Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Why is Genomic Valley Biotech Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-genomic-valley-biotech-ltd-fallingrising-3965241",
        "imagepath": "",
        "date": "2026-04-28 01:30:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Short-Term Performance</strong></p>\n<p>As of the latest available data, Genomic Valley Biotech Ltd’s shares have declined by ₹0.85, or 3.22%, signalling a negative trading session. This drop is consistent with the stock’s broader short-term trend, as it has lost 8.86% over the past week and the past month. These declines are considerably sharper than the benchmark Sensex, which fell by only 1.55% in the last week and gained 5.06% over the last month. The stock’s underperformance relative to the broader market in recent weeks suggests investor caution or profit-taking pressures weighing on the share price.</p>\n<p><strong>Year-to-Date and Longer-Term Context</strong></p>\n<p>Despite the recent weakness, Genomic Valley Biotech Ltd has managed a modest gain of 3.28% year..."
      }
    ],
    "total": 13,
    "sid": "493236",
    "stock_news_url": "https://www.marketsmojo.com/news/genomic-valley-biotech-493236"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "18-May-2026",
      "details": "Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the audited financial results (standalone) of the Company for the quarter and year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Apr-2026",
      "details": "Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011",
      "datetime": "03-Apr-2026",
      "details": "Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations 2011 for the financial year ended on March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "29 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

18-May-2026 | Source : BSE

Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the audited financial results (standalone) of the Company for the quarter and year ended March 31 2026.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

14-Apr-2026 | Source : BSE

Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st March 2026.

Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011

03-Apr-2026 | Source : BSE

Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations 2011 for the financial year ended on March 31 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

29 May 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available